Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 065421
Company: MYLAN LABS LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
RIFAMPIN RIFAMPIN 600MG/VIAL INJECTABLE;INJECTION Prescription AP No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
05/22/2008 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
10/27/2015 SUPPL-3 Labeling-Package Insert, Labeling-Package Insert

Label is not available on this site.

RIFAMPIN

INJECTABLE;INJECTION; 600MG/VIAL
TE Code = AP

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
RIFADIN RIFAMPIN 600MG/VIAL INJECTABLE;INJECTION Prescription Yes AP 050627 SANOFI AVENTIS US
RIFAMPIN RIFAMPIN 600MG/VIAL INJECTABLE;INJECTION Prescription No AP 065502 AKORN
RIFAMPIN RIFAMPIN 600MG/VIAL INJECTABLE;INJECTION Prescription No AP 204101 EMCURE PHARMS LTD
RIFAMPIN RIFAMPIN 600MG/VIAL INJECTABLE;INJECTION Prescription No AP 091181 FRESENIUS KABI USA
RIFAMPIN RIFAMPIN 600MG/VIAL INJECTABLE;INJECTION Prescription No AP 205039 HIKMA PHARMS
RIFAMPIN RIFAMPIN 600MG/VIAL INJECTABLE;INJECTION Prescription No AP 065421 MYLAN LABS LTD
RIFAMPIN RIFAMPIN 600MG/VIAL INJECTABLE;INJECTION Prescription No AP 206736 WATSON PHARMS TEVA
RIFAMPIN RIFAMPIN 600MG/VIAL INJECTABLE;INJECTION Prescription No AP 064217 WEST-WARD PHARMS INT

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English